ArticleAnnals of thoracic surgery short reports2026
Surgery for Superior Sulcus Tumor, Partially Using a Robotic Approach, After Neoadjuvant Nivolumab With Platinum-Based Chemotherapy.
Article in Annals of thoracic surgery short reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sequential robotic-assisted thoracic surgery and transmanubrial approach for optimal resection of superior sulcus tumor: a case report.Journal of visualized surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superior sulcus tumors have traditionally been treated with concurrent chemoradiotherapy followed by surgical resection, although radiation-induced fibrosis complicates surgery. Recent studies suggest that neoadjuvant nivolumab combined with platinum-based chemotherapy improves prognosis while limiting perioperative complications. We successfully performed surgical resection of a superior sulcus tumor by using a hybrid approach: an L-shaped incision for chest wall resection and a robotic-assisted technique for left upper lobectomy and lymphadenectomy. The patient achieved a major pathologic response with an uneventful recovery. This case highlights the potential of neoadjuvant immunochemotherapy and robotic surgery in optimizing outcomes for superior sulcus tumor management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.